Metabolic Syndrome and Onset of Cancer
March 15 - 16, 2006
Boston
No webcast recordings are available for this event.
Welcome
W. Allan Walker, M.D.
Conrad Taff Professor of Nutrition;
Director, Division of Nutrition, Harvard Medical School
Introductory Remarks
George Blackburn, M.D., Ph.D.
S. Daniel Abraham Associate Professor of Nutrition;
Associate Director, Division of Nutrition, Harvard Medical School
SESSION I - METABOLIC SYNDROME AND CANCER RISK: EPIDEMIOLOGICAL INVESTIGATION
Moderator:
John Milner, Ph.D.
Chief of the Nutrition Science Research Group in the Division of Cancer Prevention
National Cancer Institute
Epidemiological Evidence on Metabolic Syndrome and Cancer Development: An Overview of Epidemiological Evidence and Proposed Mechanics
Eugenia E. Calle, Ph.D.
American Cancer Society
The Role of IGF-I Signaling in Cancer Risk and Progression: A Connection Between Metabolic Syndrome and Cancer Risk
Michael N. Pollak, M.D., FRCP
McGill University
Diabetes, Metabolic Syndrome and Risk of Breast Cancer
Karin Michels, Sc.D., Ph.D.,
Brigham and Women's Hospital,
Harvard Medical School
Metabolic Syndrome, Obesity and Risk of Colon Cancer
Edward L. Giovannucci, D.Sc., M.D.,
Harvard School of Public Health
Metabolic Syndrome, Obesity and Risk of Prostate Cancer
Ann Hsing, Ph.D.,
National Cancer Institute
Panel Discussion
SESSION II - BASIC RESEARCH
Moderator:
Jin-Rong Zhou, PhD,
Assistant Professor of Surgery, Harvard Medical School;
Director, Nutrition/Metabolism Lab, Beth Israel Deaconess Medical Center
PI3K-Akt: A Central Pathway in Both Turmorigenesis and Insulin Signaling
Lewis C. Cantley, Ph.D.,
Beth Israel Deaconess Medical Center,
Harvard Medical School
The Role of Adiponectin in Cancer Development and Progression
Christos S. Mantzoros, M.D.,
Beth Israel Deaconess Medical Center,
Harvard Medical School
Free Fatty Acids, Insulin Resistance and Cancer
Richard N. Bergman, Ph.D.,
University of Southern California School of Medicine
The Role of AMPK in MS and Cancer
Neil B. Ruderman, M.D.,
Boston University Medical Center
The Potential Role of MS in Epigenetic Modulation of Carcinogenesis
Sharon A. Ross, Ph.D., M.P.H.,
National Cancer Institute
The Role of Stress and Inflammatory Pathways in Metabolic Homeostasis and Survival
Gokhan Hotamisligil, M.D., Ph.D.,
Harvard School of Public Health
Panel Discussion
SESSION III - PREVENTION AND INTERVENTION: Preclinical and Clinical Studies
Moderator:
George L. Blackburn, M.D, Ph.D.,
S. Daniel Abraham Associate Professor of Nutrition;
Associate Director, Division of Nutrition, Harvard Medical School
Dietary Fat Reduction and Breast Cancer Outcome: Results from the Women's Intervention Nutrition Study (WINS)
George L. Blackburn, M.D, Ph.D..
Harvard Medical School
Division of Nutrition
Dietary and Nutritional Combinations and Cancer Prevention: Targeting MS
Jin-Rong Zhou, Ph.D.
Insulin Sensitizers and Cancer Prevention and Treatment: PPAR-gamma Agonists
Bruce Spiegelman, Ph.D.,
Harvard Medical School,
Dana Farber Cancer Institute
Prostate Cancer Prevention by Nutritional Means to Alleviate MS
R. James Barnard, Ph.D.,
UCLA
Panel Discussion
SESSION IV - TRANSLATIONAL AND CLINICAL SCIENCE
WHI Summary and Dietary Implications
John Milner, Ph.D.,
National Cancer Institute
Panel Discussion
Closing Remarks
Dr. Walker and Dr. Blackburn